Patents by Inventor Anne Valade

Anne Valade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Octahydroisoquinolinyl Derivatives
    Publication number: 20240043400
    Abstract: The present invention relates to octahydroisoquinolinyl derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: December 1, 2021
    Publication date: February 8, 2024
    Inventors: Ali Ates, Pierre Burssens, Adrian Hall, Laurent Provins, David Skolc, Anne Valade
  • A Substituted Tetrahydroisoquinoline Derivative as a D1 Positive Allosteric Modulator
    Publication number: 20220251064
    Abstract: The present invention relates to compounds according to formula (I), which are a positive allosteric modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: June 29, 2020
    Publication date: August 11, 2022
    Inventor: Anne Valade
  • Imaging Agents
    Publication number: 20220162221
    Abstract: The present invention relates to radiolabelled 4-(furo[3,2-c]pyridin-4-yl) derivatives and their use as radioactive tracers, and in particular their use as imaging agents.
    Type: Application
    Filed: November 24, 2021
    Publication date: May 26, 2022
    Inventors: Joel Mercier, Anne Valade, Celine Vermeiren, Martyn Wood, Ralph Maquire
  • Imaging Agents
    Publication number: 20200369675
    Abstract: The present invention relates to radiolabelled 4-(furo[3,2-c]pyridin-4-yl) derivatives and their use as radioactive tracers, and in particular their use as imaging agents.
    Type: Application
    Filed: November 27, 2018
    Publication date: November 26, 2020
    Inventors: Joel Mercier, Anne Valade, Celine Vermeiren, Martyn Wood, Ralph Macquire
  • Tetrahydroisoquinoline derivatives
    Patent number: 10370355
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), wherein G represents a fused heterocyclic system selected from the groups represented by formula (G1), (G2), (G3), (G4), (G5), and (G6), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: August 6, 2019
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Ali Ates, Eric Jnoff, Laurent Provins, Anne Valade, Adrian Hall
  • Tetrahydroisoquinoline Derivatives
    Publication number: 20190106406
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), wherein G represents a fused heterocyclic system selected from the groups represented by formula (G1), (G2), (G3), (G4), (G5), and (G6), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: April 7, 2017
    Publication date: April 11, 2019
    Inventors: Ali Ates, Eric Jnoff, Laurent Provins, Anne Valade, Adrian Hall
  • Tetrahydroisoquinoline derivatives
    Patent number: 10105359
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: October 23, 2018
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Anne Valade, Eric Jnoff, Ali Ates, Pierre Burssens, David Skolc, Zara Sands, Benoit Mathieu
  • Isoindoline derivatives
    Patent number: 9975873
    Abstract: The present invention relates to isoindoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: May 22, 2018
    Assignee: UCB BIOPHARMA SPRL
    Inventors: David Skolc, Ali Ates, Eric Jnoff, Anne Valade, Benoit Mathieu, Zara Sands
  • Isoindoline Derivatives
    Publication number: 20170313677
    Abstract: The present invention relates to isoindoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: October 6, 2015
    Publication date: November 2, 2017
    Inventors: David Skolc, Ali Ates, Eric Jnoff, Anne Valade, Benoit Mathieu, Zara Sands
  • Tetrahydroisoquinoline Derivatives
    Publication number: 20170304292
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: October 6, 2015
    Publication date: October 26, 2017
    Inventors: Anne VALADE, Eric JNOFF, Ali ATES, Pierre BURSSENS, David SKOLC, Zara SANDS, Benoit MATHIEU
  • 2-oxo-piperidinyl derivatives
    Patent number: 9067930
    Abstract: The present invention relates to 2-oxo-piperidinyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: June 30, 2015
    Assignee: UCB Pharma, S.A.
    Inventors: Ali Ates, Florian Montel, Anne Valade, Olivier Lorthioir
  • 2-Oxo-Piperidinyl Derivatives
    Publication number: 20150011526
    Abstract: The present invention relates to 2-oxo-piperidinyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: October 10, 2012
    Publication date: January 8, 2015
    Inventors: Ali Ates, Florian Montel, Anne Valade, Olivier Lorthioir
  • Compounds Comprising A Cyclobutoxy Group
    Publication number: 20110098300
    Abstract: The present invention relates to compounds of formula (I) comprising a cyclobutoxy group, processes for preparing them, pharmaceutical compositions comprising said compounds and their use as pharmaceuticals, useful for the treatment and prevention of diseases or pathological conditions of the central nervous system including mild-cognitive impairments, Alzheimer's disease, learning and; memory disorders, cognitive disorders, attention deficit disorder, attention-deficit hyperactivity disorder, Parkinson's disease, schizophrenia, dementia, depression, epilepsy, seizures, convulsions, sleep/wake and arousal/vigilance disorders such as hypersomnia and narcolepsy, pain and/or obesity.
    Type: Application
    Filed: June 2, 2009
    Publication date: April 28, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Sylvain Celanire, Laurent Provins, Frederic Denonne, Anne Valade
  • Compounds Comprising a Cyclobutoxy Group
    Publication number: 20100305116
    Abstract: The present invention relates to compounds comprising a cyclobutoxy group, processes for preparing them, phar-maceutical compositions comprising said compounds and their use as pharmaceuticals.
    Type: Application
    Filed: April 14, 2008
    Publication date: December 2, 2010
    Applicant: UCB PHARMA, S.A.
    Inventors: Sylvain Celanire, Frederic Denonne, Anne Valade
  • Compounds Comprising A Cyclobutoxy Group
    Publication number: 20100292188
    Abstract: The present invention relates to compounds of formula (I) comprising a cyclobutoxy group, processes for preparing them, pharmaceutical compositions comprising said compounds and their use as pharmaceuticals.
    Type: Application
    Filed: January 22, 2009
    Publication date: November 18, 2010
    Applicant: UCB PHARMA S.A.
    Inventors: Frédéric Denonne, Sylvain Celanire, Anne Valade, Sabine Defays, Véronique Durieu